We have participated in more than 200 successful projects with broad range of parnters from small startups to big multinational companies
BDI biotech is your partner to bring the benefits of biotechnology into your current production processes. We have been bringing projects from bench to reality since 2016. In this way, we help many agricultural, industrial, food and cosmetic companies.
BDI biotech is pioneer in the field of specialty enzyme production, driving innovation in projects centered around the overproduction and utilization of enzymes essential in pharmaceutical, nutraceuticals or cosmetics formulations and/or manufacturing processs, contributing to the development of novel products or improving the efficiency of already existing ones.
We have cultivated a deep understanding of microbial physiology, fermentation technologies, and downstream processing techniques, allowing us to optimize enzyme production at scale while minimizing costs. Our tailored solutions cater to the diverse needs of the pharmaceutical, cosmetic or food industry, offering cost-effective enzyme products and production processes that meet stringent quality standards and regulatory requirements.
With a focus on harnessing the potential of live microorganisms for therapeutic purposes, we have successfully executed numerous projects that have paved the way for advancements in healthcare. Our team of experts possesses a deep understanding of the complexities involved in developing and manufacturing LBPs, ensuring that each project is tailored to meet the unique needs and objectives of our clients.
From initial concept to final delivery, we work closely with our clients to navigate the challenges inherent in LBP development, including strain selection, process development, and regulatory compliance. Our proven track record speaks volumes about our ability to deliver results that exceed expectations, driving positive outcomes for both our clients and the patients they serve.
In the dairy sector, biotechnology emerges as the modern approach to streamline the complete value chain. BDI biotech takes advantage of this potential to efficiently generate proteins like casein, alpha-lactalbumin, beta-lactoglobulin, lactoperoxidase and lactoferrin through innovative overexpression techniques. Our expertise extends to optimizing fermentation conditions and purification steps culminating in a highly efficient and cost-effective production process.
BDI biotech has worked in a broad range of projects developing meat substitutes for vegan and vegetarian products. For example, we have produced single cell proteins (SCP) like Fusarium, Torula or Saccharomyces with the aim of recreating the consistency of meat texture.
To provide a meaty taste, we have developed microbial strains and processes for the overproduction of myoglobins and hemoglobins as flavoring products. We have also worked on the overproduction of recombinant growth factors for cultured meat. For all of those projects we have provided the client with data on the techno-economic feasibility.
BDI biotech transform substrates into high-value products through precision fermentation and/or using enzymatic biocatalysts. We promote the circular economy, offering process development and contract manufacturing services to companies committed to a greener and more prosperous future.
During these years, BDI biotech has worked with a diverse range of enzymes essential for biotransformation of raw materials into desired products. This includes enzymes such as cytochrome P450, oxidases or glycosidases, among others. By employing whole organism approaches, BDI biotech is dedicated to delivering economic viable high-quality flavorings, additives, and other valuable biotechnological products.
We do not have our own catalogue of products since we develop and overproduce for third parties non-commoditized but their branded specialty products.
BDI biotech has participated in the isolation and manufacturing of probiotics for yogurts and other dairy products. We have also worked improving fermentation recipes to obtain allergens-free probiotics or new probiotics for infant formulas, other foods matrixes and also feed applications, etc. Lot of probiotics has also demonstrated their effectiveness in skin-friendly cosmetic products, and we have worked with some companies developing the manufacturing process of their selected strains.
Any upcoming project? Contact our team and let’s explore possible ways of collaboration
DESARROLLO DE UNA VACUNA DE COMPLEJO INMUNE CONTRA LA BURSITIS INFECCIOSA AVIAR A PARTIR DE PARTÍCULAS PSEUDO-VIRALES NO INFECCIOSAS
Expediente nº: RTC-2019-007162-2
Plazo de realización: Desde el 01/01/2020 al 30/09/2023
Proyecto financiado por el Ministerio de Ciencia e Innovación y la Agencia Estatal de Investigación, con el objetivo de potenciar la investigación, el desarrollo tecnológico y la innovación.
CULTUREDMEAT: INVESTIGACIÓN EN LOS CÁRNICOS DEL FUTURO DESTINADOS A LA PREVENCIÓN DE CÁNCER DE COLON Y DISLIPEMIAS
Objetivo: Investigación en carne producida en laboratorio junto a la obtención sostenible y adición de grasas saludables e ingredientes funcionales para la prevención de dislipemias y cáncer de colon.
Lugar de realización: Parque Tecnológico de Boecillo (Valladolid)
Expediente: EXP 001334599/MIG-20201012
Proyecto subvencionado por el CDTI y apoyado por el Ministerio de Ciencia, Innovación y Universidades, y fondos provenientes de FEDER, Fondo Europeo de Desarrollo Regional “Una manera de hacer Europa”.
IMPLANTACIÓN SISTEMA DE GESTIÓN DE CALIDAD SEGÚN NORMA ISO 9001:2015
Expediente nº: 03/18/VA/0007
Plazo de realización: Desde el 10/04/2019 al 31/03/2020
Proyecto financiado por el FEDER de la Unión Europea y la Junta de Castilla y León, a través del ICE, con el objetivo de conseguir un tejido empresarial más competitivo digitalmente
2BCELL - PRODUCCIÓN DE BIOCELULOSA COMO INGREDIENTE PARA PRODUCTOS DE APLICACIÓN EN EL SECTOR DEL CUIDADO PERSONAL
Expediente: EXP 00157210 / CIIP-20221017
Este proyecto ha recibido financiación del programa conjunto Eurostars-3 con cofinanciación de CDTI y del Programa Marco de Investigación e Innovación Horizonte Europa de la Unión Europea.
DESARROLLO DE PCVax, UNA VACUNA BIOTECNOLÓGICA CONTRA EL CIRCOVIRUS PORCINO BASADA EN PARTÍCULAS PSEUDOVIRALES QUIMÉRICAS (CH-VLPs)
EXPEDIENTE: RTC-2017-6315-2
PLAZO DE REALIZACIÓN: Desde el 01/07/2018 al 31/12/2020
Proyecto financiado por el Ministerio de Ciencia, Innovación y Universidades- Agencia Estatal de Investigación, y cofinanciado por la Unión Europea con el objetivo de Promover el desarrollo tecnológico, la innovación y una investigación de calidad
